Investigational Site Number : 2760061

Bremen 28205

0 studies enrolling now · 1 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) — Completed